The role of surgery for high-risk prostate cancer

被引：0
|
作者：
Ucer, Oktay [1 ]
Muezzinoglu, Talha [1 ]
机构：
[1] Celal Bayar Univ, Tip Fak, Urol Anabilim Dali, Manisa, Turkey
来源：
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2014年 / 13卷 / 01期
关键词：
high-risk prostate cancer; radical prostatectomy; prostate cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Because of PSA screening, urologists can detect clinically localized prostate cancer in patients before the disease has progressed to advanced stages. Nevertheless, some patients are still diagnosed with high-risk prostate cancer. Surgery for high-risk prostate cancer is applied frequently nowadays. Nevertheless, this approach is still surrounded by many controversies. In some high-risk prostate cancer patients, surgery is a one-step modality in treatment and has an excellent oncological prognosis. However, because of the lack of evidence and well-controlled comparative prospective studies, the best course of treatment can be unclear, and oncological outcomes often appear heterogeneous. The aim of this review is to discuss the role of surgery in high risk prostate cancer.
引用
收藏
页码：21 / 24
页数：4
相关论文
共 50 条
  • [41] News and perspective in management of high-risk prostate cancer
    Audenet, F.
    Roupret, M.
    PROGRES EN UROLOGIE, 2011, 21 : S80 - S83
  • [42] High-risk localized prostate cancer: Integrating chemotherapy
    Oh, WK
    ONCOLOGIST, 2005, 10 : 18 - 22
  • [43] The role for surgeryin high-risk prostate cancer; [Die Rolle der Chirurgie bei Hochrisiko-Prostatakrebs]
    Lanchon C.
    F. Shariat S.
    Rouprêt M.
    Wiener Medizinische Wochenschrift, 2015, 165 (19-20) : 395 - 400
  • [44] Neoadjuvant therapy for high-risk localized prostate cancer
    Evan Y. Yu
    William K. Oh
    Current Oncology Reports, 2003, 5 (3) : 250 - 257
  • [45] Survival Differences in High-Risk Prostate Cancer by Age
    Garcia-Fuentes, Clara
    Guijarro, Ana
    Hernandez, Virginia
    Gonzalo-Balbas, Alvaro
    Jimenez-Alcaide, Estibaliz
    de la Pena, Enrique
    Perez-Fernandez, Elia
    Llorente, Carlos
    UROLOGY JOURNAL, 2023, 20 (04) : 215 - 221
  • [46] Contemporary treatment of high-risk localized prostate cancer
    Tareen, Basir
    Kimmel, Joseph
    Huang, William C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (07) : 1069 - 1076
  • [47] Neoadjuvant and adjuvant treatment in high-risk prostate cancer
    Bandini, Marco
    Fossati, Nicola
    Gandaglia, Giorgio
    Preisser, Felix
    Dell'Oglio, Paolo
    Zaffuto, Emanuele
    Stabile, Armando
    Gallina, Andrea
    Suardi, Nazareno
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    Briganti, Alberto
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 425 - 438
  • [48] The Central Role of Radiation in Prolonging Survival for High-Risk Prostate Cancer
    Shumway, Dean A.
    Hamstra, Daniel A.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (05) : 18 - 22
  • [49] High-Risk Prostate Cancer: Role of Radical Prostatectomy and Radiation Therapy
    Qi, Robert
    Moul, Judd
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (12) : 639 - 644
  • [50] The role of intravenous zoledronic acid in the management of high-risk prostate cancer
    Gilbert, SM
    Olsson, CA
    Benson, MC
    McKiernan, JM
    CURRENT OPINION IN UROLOGY, 2003, 13 (02) : 133 - 135
12345